See the DrugPatentWatch profile for Ameluz
What is Ameluz (aminolevulinic acid) used for?
Ameluz is a prescription medicine used in photodynamic therapy (PDT) for certain skin conditions. It contains the active ingredient aminolevulinic acid, which is applied to the skin and then activated by light to target abnormal cells or lesions. [1]
What conditions can Ameluz treat?
The product is used for selected indications related to abnormal growths on the skin, most notably actinic keratosis (sun-damaged, precancerous lesions). [1]
How is Ameluz typically applied and what does the light treatment do?
Ameluz is applied to the affected skin area and then exposed to a specific light source during photodynamic therapy. The light activation helps convert the medicine in the skin into a form that can damage targeted abnormal cells. [1]
How long does treatment take and how many sessions are needed?
The overall timeline depends on the treated condition and the treatment protocol using a light source. Typical PDT regimens involve treatment sessions separated by days to weeks, but the exact schedule should follow the prescriber’s instructions and the approved product guidance. [1]
What side effects do patients usually notice?
Common effects are local skin reactions where the medicine is applied, such as redness, swelling, and irritation, which are expected in PDT because the target area is being treated with light. [1]
Is Ameluz the same as other aminolevulinic acid products?
Ameluz is specifically the brand name for aminolevulinic acid used in PDT. Other products may use related active ingredients or different formulations, so switching products should be done only based on clinician guidance and the approved labeling. [1]
Where can Ameluz be prescribed and obtained?
Ameluz is a prescription product, so it is typically obtained through a healthcare provider who confirms the indication and sets up the PDT with the appropriate light equipment. [1]
Sources
- https://www.ema.europa.eu/en/medicines/human/EPAR/ameluz